SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Solid Biosciences Expects Initial FALCON Clinical Data in Q1 2027

Valid market news retained in the public archive without immediate LiveCast distribution.

SLDB

Story updates

12:06:33 PM UTC
SquawkNews
Solid Biosciences Inc. (SLDB) Wins EU Orphan Status for FA Gene Therapy; 5 Dosed in Phase 1b

Related stories